Target intelligence / Profile preview

LIM and senescent cell antigen-like-containing domain protein 3 (LIMS3)

Target
LIMS3
Molecular classification
Other (LIM domain-containing protein, adaptor protein)
01

Overview

LIM and senescent cell antigen-like-containing domain protein 3 (LIMS3) is a member of the LIM domain-containing protein family, which are characterized by having one or more LIM domains—a zinc finger protein motif specialized for mediating protein-protein interactions and not for direct DNA binding[1][3][6][7]. LIM domain proteins act as scaffolds or adaptors that organize multiprotein complexes, especially at sites related to the cytoskeleton such as focal adhesions and cell adhesion structures[2][7]. Although some LIM domain proteins are important in development and disease, LIMS3 is not established in the literature as a major therapeutic target, and there is limited or no evidence of its involvement in drug interactions, signaling pathways, or disease associations. Its alternative names, such as PINCH3 and variants thereof, refer to its putative homology within the PINCH family, which generally participates in cell adhesion and cytoskeletal architecture, but LIMS3 itself is poorly characterized functionally or therapeutically in available scientific resources[6].

Other names
PINCH3PINCH-3Particularly interesting new Cys-His protein 3pinch 2LIMS3LLIMS4LIM and senescent cell antigen-like domains 3LIM and senescent cell antigen-like-containing domain protein 3-likeLIM and senescent cell antigen-like-containing domain protein 4LIM-type zinc finger domains 3
02

Biological functions

Protein-protein interactionCytoskeletal organizationCell adhesionSignal transduction

Beyond the preview

Go deeper on LIM and senescent cell antigen-like-containing domain protein 3 (LIMS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LIM and senescent cell antigen-like-containing domain protein 3 (LIMS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call